Novomics Company Description

Novomics Co., Ltd. designs and develops genetic molecular diagnostics solutions.

The company offers nProfiler1 Expansion Stomach Cancer Assay to analyze the gene expression profiles of stage II-III gastric cancer.

It also provides nProfiler 2, a cancer variant assay; AI assisted digital pathology and auto sampling system; nProfiler, a breast cancer assay; nProfiler, a colon cancer assay; nProfiler, a rectal cancer assay; and nProfiler, a cOVID-19 detection kit.

The company was formerly known as Novomics Meditech Co., Ltd. and changed its name to Novomics Co., Ltd. in July 2015.

Novomics Co., Ltd. was founded in 2010 and is based in Seoul, South Korea.

Novomics Co., Ltd.

Country	South Korea
Founded	2010
Industry	In Vitro and In Vivo Diagnostic Substances

Contact Details

Address: 304,305,306,306-1 KeumKang Penterium IT Tower Seoul, 07217 South Korea
Phone	82 2 2068 3700
Website	novomics.com

Stock Details

Ticker Symbol	283100
Exchange	Korea New Exchange
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	2835